Bookmark

Add to MyYahoo RSS

Selecta Biosciences News

News on Selecta Biosciences continually updated from thousands of sources around the net.

Dec 9, 2013 | Hispanic Business

Selecta Biosciences Announces Successful Pre-clinical Study of...

SEL-201 demonstrated the ability to induce immune tolerance in a model of hemophilia A, showing that SEL-201 has the potential to serve as an adjunct therapy to avoid harmful neutralizing antibody response to Factor VIII treatment severely affecting hemophilia A patients.

Comment?

Related Topix: Hemophilia, Health

Tue Aug 27, 2013

Hispanic Business

Selecta Biosciences Distinguished as World Economic Forum Technology Pioneer 2014

Selecta Biosciences , innovator of immune targeting technology -platform%2Findex.cfm&esheet=50697499&newsitemid=20130827005481&lan=en-US&anchor=Synthetic+Vaccine+Particles+%28SVP%E2%84%A2%29&index=2&md5=867d510b0dab40a162b6fa6ec60341e6">Synthetic Vaccine Particles , has been awarded Technology Pioneer 2014 by the .

Comment?

Related Topix: Malaria, Medicine, Health

Wed Nov 28, 2012

Mass High Tech

Selecta makes $900M deal with Sanofi

Selecta Biosciences Inc. in Watertown said Wednesday that it's made a deal with global drug developer Sanofi, worth up to $900 million, to discover immunotherapies for life-threatening food and other types of allergies.

Comment?

Related Topix: Medicine, Allergy

Tue Nov 27, 2012

Customer Interaction Solutions

Selecta Biosciences and Sanofi Sign Global Collaboration to Develop...

Selecta Biosciences, Inc. , a clinical-stage biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies.

Comment?

Related Topix: Vaccinations, Health, Immunology, Biology, Science

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••